Bhutan vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Bhutan
100.0%
in 2024
South-East Asia (WHO region)
94.0%
in 2024
Bhutan rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bhutan
- South-East Asia (WHO region)
How they compare
Bhutan currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Bhutan's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 2 times across 14 shared years of data; in 2008 it was Bhutan ahead.
Bhutan ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 45.5% | 54.5% | Bhutan |
| 2010s | 92.9% | 83.6% | 9.3% | Bhutan |
| 2020s | 100.0% | 92.2% | 7.8% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bhutan or South-East Asia (WHO region)?
- Bhutan, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bhutan and South-East Asia (WHO region)?
- 6.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and South-East Asia (WHO region)?
- 14 years are reported by both, from 2008 to 2024.
- How do Bhutan and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bhutan ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.